Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 9Recruiting 5Withdrawn 4Not yet recruiting 4Unknown 3Terminated 3Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Prostatic Neoplasms 25Breast Neoplasms 21Glioblastoma 19Carcinoma, Non-Small-Cell Lung 17Sarcoma 11Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Rectal Neoplasms 8Neoplasms 8Hodgkin Disease 8Head and Neck Neoplasms 8Brain Neoplasms 8Oropharyngeal Neoplasms 7Glioma 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Pancreatic Neoplasms 6Astrocytoma 6Triple Negative Breast Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Carcinoma, Squamous Cell 5Neoplasm Metastasis 4Melanoma 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Small Cell Lung Carcinoma 3Rhabdomyosarcoma 3Recurrence 3

Interventions

Carboplatin 15durvalumab 14Etoposide 14pembrolizumab 9atezolizumab 9Cisplatin 9Topotecan 8Nivolumab 7Specimen Handling 6olaparib 4berzosertib 4Temozolomide 4Magnetic Resonance Spectroscopy 4AMG 757 4tremelimumab 3Radiotherapy 3Radiosurgery 3PM 01183 3Ipilimumab 3Docetaxel 3Biopsy 3niraparib 2lenvatinib 2cabozantinib 2Platinum 2Irinotecan 2Fulvestrant 2veliparib 1tislelizumab 1tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Small Cell Lung Carcinoma × Radiotherapy × Clear all
NCT05092412 2026-05-08

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Sichuan University

Phase 2 Active not recruiting
30 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05765825 2026-04-29

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

Sichuan University

Phase 2 Active not recruiting
61 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04562337 2024-07-03

SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC

Shandong Cancer Hospital and Institute

Phase 2 Active not recruiting
67 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡